Hot Pursuit     20-Feb-25
Biocon Ltd eases for fifth straight session
Biocon Ltd is quoting at Rs 332.25, down 1.35% on the day as on 13:19 IST on the NSE. The stock jumped 21.26% in last one year as compared to a 3.77% rally in NIFTY and a 9.52% spurt in the Nifty Pharma index.

Biocon Ltd dropped for a fifth straight session today. The stock is quoting at Rs 332.25, down 1.35% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.21% on the day, quoting at 22885.7. The Sensex is at 75690.47, down 0.33%.Biocon Ltd has eased around 14.93% in last one month.Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has eased around 5.33% in last one month and is currently quoting at 20820, down 0.49% on the day. The volume in the stock stood at 16.49 lakh shares today, compared to the daily average of 35.66 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 333, down 1.27% on the day. Biocon Ltd jumped 21.26% in last one year as compared to a 3.77% rally in NIFTY and a 9.52% spurt in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 24.

Previous News
  Biocon unit gets U.S. FDA nod for cancer drug biosimilar
 ( Hot Pursuit - 10-Apr-25   11:07 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 12-Jul-24   13:36 )
  Biocon to consider fund Raising
 ( Corporate News - 21-Apr-25   09:37 )
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Biocon announces resignation of senior management
 ( Corporate News - 08-Feb-24   19:49 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 27-Dec-24   13:05 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
Other Stories
  Maruti Suzuki records PAT of Rs 3,711.1 crore in Q4; Op. EBIT margin at 8.7%
  25-Apr-25   15:00
  SRM Contractors Ltd leads losers in 'B' group
  25-Apr-25   14:45
  Chennai Petro rises after Q4 PAT skyrockets to Rs 470 crore; declares dividend of Rs 5/sh
  25-Apr-25   14:44
  Volumes soar at Indian Energy Exchange Ltd counter
  25-Apr-25   14:30
  Escorts Kubota announces price hike for tractors effective from May’25
  25-Apr-25   14:21
  Tech Mahindra gains after Q4 PAT rises 19% QoQ; declares dividend of Rs 30/sh
  25-Apr-25   14:20
  Utilties stocks edge lower
  25-Apr-25   14:00
  Nelco slumps after reporting dismal Q4 numbers
  25-Apr-25   13:07
  Tech Mahindra Ltd soars 0.67%, up for fifth straight session
  25-Apr-25   13:00
  LTTS tumbles as Q4 PAT slides 4% QoQ; declares dividend of Rs 38/sh
  25-Apr-25   12:37
Back Top